Biocon's Mazumdar Shaw Says Firm On Track To Be Top Insulin Maker

Biocon founder Kiran Mazumdar Shaw says she is confident that the company's investment and capacity expansion in Insulin will make the company the top hub for the drug in the next five years. She speaks in an exclusive conversation with Bloomberg's Haslinda Amin. (Source:…

To respect copyright, we link to the source rather than republishing the full text. Read the complete article on Bloomberg.